探索气道生物障碍:IgG基疗法在呼吸道感染中的影响
Gabrielle Pichon1, Christelle Parent1, Stefanie Graeter2
1INSERM, Research Center for Respiratory Diseases, U1100, F-37032 Tours, France; University of Tours F-37032 Tours, France.
概括
吸入的免疫球蛋白G (IgG) 由于粘液和生物膜屏障,在呼吸道感染中有效性降低. 然而,IgG可以破坏细菌生物膜,支持其在慢性肺部疾病中的使用.
科学领域:
- 肺部医学 肺部医学
- 免疫学 免疫学 免疫学
- 微生物学 微生物学
背景情况:
- 呼吸道感染对健康造成重大负担,因抗生素耐药性增加而加剧.
- 吸入性免疫球蛋白G (IgG) 疗法在向肺部感染方面表现有前途.
- 呼吸道中的物理和生物障碍可能会阻碍吸入IgG的疗效.
研究的目的:
- 研究呼吸道感染相关障碍对吸入IgG功能的影响.
- 评估IgG在肺部感染中克服粘液和生物膜挑战的能力.
- 评估吸入IgG治疗慢性肺部疾病的潜力.
主要方法:
- 利用了具有健康和支气管切除症类特征的人造粘液模型.
- 在不同的粘液环境中评估IgG流动性和病原体结合.
- 在实验室中研究了IgG对Pseudomonas aeruginosa生物膜完整性的影响.
主要成果:
- 吸入的IgG在支气管切除症类粘液中表现出减少的运动性和病原体结合性.
- 在感染相关的呼吸道疾病中,IgG的opsonization和效应器功能受损.
- 在体外多次使用IgG破坏了P. aeruginosa生物膜的完整性.
结论:
- 物理障碍,如厚的粘液,显著阻碍了吸入IgG在呼吸道感染中的有效性.
- 通过破坏细菌生物膜,IgG显示出治疗慢性肺病的潜力.
- 必须解决与透障碍相关的挑战,才能成功开发吸入性IgG疗法.
相关概念视频
Drugs Used in Lower Respiratory Disorders: Overview
589
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
589
Asthma: Pathogenesis and Management
597
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
597
Asthma-II: Pathophysiology and Classification
2.9K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.9K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
464
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
464
Asthma-I: Introduction
2.8K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.8K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
3.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
3.1K


